SNWV — SANUWAVE Health Income Statement
0.000.00%
Last trade - 00:00- $270.23m
- $284.00m
- $32.63m
- 46
- 47
- 79
- 60
Annual income statement for SANUWAVE Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4.06 | 13 | 16.7 | 20.4 | 32.6 |
| Cost of Revenue | |||||
| Gross Profit | 2.9 | 8.02 | 12.4 | 14.4 | 24.6 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 29.8 | 30.5 | 29.5 | 20.9 | 20.9 |
| Operating Profit | -25.8 | -17.5 | -12.8 | -0.54 | 11.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -30.9 | -27.2 | -10.3 | -25.8 | -31.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -30.9 | -27.3 | -10.3 | -25.8 | -31.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -30.9 | -27.3 | -10.3 | -25.8 | -31.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -30.9 | -27.3 | -10.3 | -25.8 | -31.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -21.9 | -18.1 | -5.31 | -12.2 | -7.95 |